BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36754376)

  • 1. Robot-assisted retroperitoneal lymph node dissection: a systematic review of perioperative outcomes.
    Garg H; Mansour AM; Psutka SP; Kim SP; Porter J; Gaspard CS; Dursun F; Pruthi DK; Wang H; Kaushik D
    BJU Int; 2023 Jul; 132(1):9-30. PubMed ID: 36754376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections.
    Lloyd P; Hong A; Furrer MA; Lee EWY; Dev HS; Coret MH; Adshead JM; Baldwin P; Knight R; Shamash J; Alifrangis C; Stoneham S; Mazhar D; Wong H; Warren A; Tran B; Lawrentschuk N; Neal DE; Thomas BC
    World J Urol; 2022 Jan; 40(1):119-126. PubMed ID: 34599350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
    Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
    Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Robot-assisted Retroperitoneal Lymph Node Dissection for Men with Nonseminomatous Germ Cell Tumor: Experience from a Multi-institutional Cohort.
    Taylor J; Becher E; Wysock JS; Lenis AT; Litwin MS; Jipp J; Langenstroer P; Johnson S; Bjurlin MA; Tan HJ; Lane BR; Huang WC
    Eur Urol Focus; 2021 Nov; 7(6):1403-1408. PubMed ID: 32682794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of laparoscopic, robotic, and open retroperitoneal lymph node dissection for non-seminomatous germ cell tumor: a single-center retrospective cohort study.
    Lin J; Hu Z; Huang S; Shen B; Wang S; Yu J; Wang P; Jin X
    World J Urol; 2023 Jul; 41(7):1877-1883. PubMed ID: 37332060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robot-assisted retroperitoneal lymph node dissection: Initial experience in Japan.
    Takahara K; Motonaga T; Okumura J; Yamakawa S; Yagi K; Nakamura W; Saruta M; Nukaya T; Takenaka M; Zennami K; Ichino M; Sasaki H; Sumitomo M; Shiroki R
    Asian J Endosc Surg; 2024 Jan; 17(1):e13262. PubMed ID: 37944943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based analysis of cost and peri-operative outcomes between open and robotic primary retroperitoneal lymph node dissection for germ cell tumors.
    Bhanvadia R; Ashbrook C; Bagrodia A; Lotan Y; Margulis V; Woldu S
    World J Urol; 2021 Jun; 39(6):1977-1984. PubMed ID: 32797261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients.
    Cheney SM; Andrews PE; Leibovich BC; Castle EP
    BJU Int; 2015 Jan; 115(1):114-20. PubMed ID: 24825773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the perioperative outcomes of laparoscopic and open retroperitoneal lymph node dissection for low-stage (stage I/II) testicular germ cell tumors: a systematic review and meta-analysis.
    Ge S; Gan L; Meng C; Li K; Wang Z; Zeng Z; Zheng L; Li Y
    Int J Surg; 2023 Apr; 109(4):995-1005. PubMed ID: 36917132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical efficacy and safety of robotic retroperitoneal lymph node dissection for testicular cancer: a systematic review and meta-analysis.
    Yuan Y; Zhang D; Ning Y; Luo H; Qiu X; Tan Y; Li Y; Yang X
    Front Oncol; 2023; 13():1257528. PubMed ID: 38169835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart review.
    Notarfrancesco M; Fankhauser CD; Lorch A; Ardizzone D; Helnwein S; Hoch D; Hermanns T; Thalmann G; Beyer J
    Swiss Med Wkly; 2023 Apr; 153():40053. PubMed ID: 37080191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
    Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
    J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-chemotherapy Laparoscopic Retroperitoneal Lymph Node Dissection for Mixed Malignant Germ Cell Testicular Tumors.
    Pickersgill NA; Raval NS; Kim EH; Black RG; Du K; Figenshau RS
    Clin Genitourin Cancer; 2021 Jun; 19(3):273.e1-273.e5. PubMed ID: 33139148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G
    Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
    Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
    Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
    Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic retroperitoneal lymph node dissection for primary and post-chemotherapy testis cancer.
    Nason GJ; Kuhathaas K; Anson-Cartwright L; Jewett MAS; O'Malley M; Sweet J; Hansen A; Bedard P; Chung P; Hahn E; Warde P; Hamilton RJ
    J Robot Surg; 2022 Apr; 16(2):369-375. PubMed ID: 33982173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumour: A systematic review.
    Haarsma R; Blok JM; van Putten K; Meijer RP
    Eur J Surg Oncol; 2020 Jun; 46(6):999-1005. PubMed ID: 32173176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.